![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/06 | |
A61K 38/48 | |||
A61K 38/55 | |||
A61K 38/57 | |||
A61K 39/395 | |||
A61K 47/50 | |||
C07K 14/81 | |||
C07K 16/36 | |||
C07K 16/40 | |||
A61P 25/00 | |||
A61P 37/00 | |||
A61K 38/17 |
(11) | Number of the document | 2809336 |
(13) | Kind of document | T |
(96) | European patent application number | 13701651.5 |
Date of filing the European patent application | 2013-01-31 | |
(97) | Date of publication of the European application | 2014-12-10 |
(45) | Date of publication and mention of the grant of the patent | 2018-06-20 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2013/051832 |
Date | 2013-01-31 |
(87) | Number | WO 2013/113774 |
Date | 2013-08-08 |
(30) | Number | Date | Country code |
12153341 | 2012-01-31 | EP | |
201261592652 P | 2012-01-31 | US |
(72) |
MEUTH, Sven, DE
GOEBEL, Kerstin, DE
KLEINSCHNITZ, Christoph, DE
MCKENZIE, Brent, US
NOLTE, Marc, DE
|
(73) |
CSL Behring GmbH,
Emil-von-Behring-Strasse 76, 35041 Marburg,
DE
Westfälische Wilhelms-Universität Münster, Schlossplatz 2, 48149 Münster, DE CSL Limited, 45 Poplar Road, Parkville VIC 3052, AU Julius-Maximilians-Universitaet Wuerzburg, Sanderring 2, 97070 Wuerzburg, DE |
(54) | FACTOR XII INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL INFLAMMATORY DISORDERS |
FACTOR XII INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL INFLAMMATORY DISORDERS |